Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03885167 · ClinicalTrials.gov registry record
Identification of Biomarkers in Spinocerebellar Ataxia 3
A clinical trial of Spinocerebellar Ataxia Type 3, sponsored by University of Michigan.
- Completed
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT03885167 is a study of Spinocerebellar Ataxia Type 3 that has completed, run by University of Michigan. The registered enrollment target is 22 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03885167, a study of Spinocerebellar Ataxia Type 3, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the differences in cerebral spinal fluid (CSF) and blood of patients with spinocerebellar ataxias and healthy volunteers. The goal of this project is to identify new biomarkers that are useful for characterizing spinocerebellar ataxias and identify targets for treatment or prevention of this condition.
Conditions Studied
Interventions
- OTHER Specimen Collection
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-02-21 |
| Est. Completion | 2023-01-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03885167
The ClinicalTrials.gov registry entry for NCT03885167 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spinocerebellar Ataxia Type 3 appearing as the primary indexed condition, and to 1 intervention - of which Specimen Collection is the first listed.
NCT03885167 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03885167 about?
NCT03885167 is a clinical study titled "Identification of Biomarkers in Spinocerebellar Ataxia 3". The purpose of this study is to examine the differences in cerebral spinal fluid (CSF) and blood of patients with spinocerebellar ataxias and healthy volunteers. The goal of this project is to identify new biomarkers that are useful for characterizing spinocerebellar ataxias and identify targets for...
What is the current status of trial NCT03885167?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2019-02-21. Estimated completion is 2023-01-04.
What conditions does trial NCT03885167 study?
This clinical trial studies the following conditions: Spinocerebellar Ataxia Type 3.
What interventions are being tested in trial NCT03885167?
The interventions under investigation include: Specimen Collection (OTHER).
Who is sponsoring clinical trial NCT03885167?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03885167 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinocerebellar Ataxia Type 3
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.